医保谈判背景下某院在用抗肿瘤药物综合干预效果与分析  

Effect of Comprehensive Intervention on the Rational Use of Anti-Cancer Drugs in a Hospital Under the Background of Medical Insurance Negotiation

作　　者：汪磊[1] 何勇[1] WANG Lei;HE Yong(The People’s Hospital of Chizhou,Anhui,China 247000)

机构地区：[1]安徽省池州市人民医院,安徽池州247000

出　　处：《中国药业》2021年第14期15-19,共5页China Pharmaceuticals

摘　　要：目的提升医院抗肿瘤药物的合理使用水平。方法通过医院信息系统,提取某院2018年7月至12月(综合干预前)、2019年1月至6月(综合干预后)在用的医保谈判抗肿瘤药物(含新型抗肿瘤药物)品种数据,对在用抗肿瘤药物的品规、价格、用量、总金额、用药频度(DDDs)、限定日剂量(DDD)、限定日费用(DDC)、药物利用指数(DUI)等进行统计与分析。结果综合干预后,该院在用医保谈判抗肿瘤药物目录品种占总品种的比例由23.33%增至43.33%;目录内药品价格大幅下降,降幅最高达70.66%,各品种单包装平均降价722.09元,平均降幅40.45%;目录内部分药品用量增加,增幅最高达4925.00%,多西他赛注射液和注射用盐酸表柔比星使用量不同程度下降;DDDs除多西他赛注射液外均不同程度升高,最高达9540;DDC值均较综合干预前下降,DUI趋于合理,抗肿瘤药物使用金额明显降低。结论医保谈判大幅降低了抗肿瘤药物的价格,在此政策利好及综合干预下,该院抗肿瘤药物的临床使用趋于合理、规范。同时,研究数据可为医院抗肿瘤药物的采购与保供机制的完善及新型抗肿瘤药物的使用管理提供参考。Objective To improve the level of rational drug use in a hospital.Methods The data of anti-cancer drugs related to medical insurance negotiation(including novel anti-cancer drugs)used in a hospital from July to December 2018(before the comprehensive intervention)and from January to June 2019(after the comprehensive intervention)were extracted from the hospital information system(HIS).The statistical analysis was carried out on the number of varieties,prices,total use amount,defined daily doses(DDDs),defined daily dose(DDD),defined daily cost(DDC),drug utilization index(DUI),etc.Results After the comprehensive intervention,the proportion of anti-cancer drugs in the catalogue of medical insurance negotiation in our hospital increased from 23.33%to 43.33%,and the price of drugs in the catalogue decreased significantly,with a maximum decrease of 70.66%.The average reduction in price of each variety per package was 722.09 CNY,with an average decrease of 40.45%.The consumption of some drugs in the catalogue increased,with a maximum increase of 4925.00%,and the consumption of Docetaxel Injection and Epirubicin Hydrochloride for Injection decreased in varying degrees.Except for Docetaxel Injection,the DDDs of other drugs increased in varying degrees,the highest DDDs was9540.The DDC values of drugs were lower than those before the comprehensive intervention,the DUI was reasonable,and the amount of money of anti-cancer drugs used has decreased significantly.Conclusion The medical insurance negotiation has greatly reduced the price of anti-cancer drugs.Through the favorable policy and comprehensive intervention,the clinical use of anti-cancer drugs in the hospital has become more reasonable and standardized.Meanwhile,the research data can provide a reference for the improvement of purchasing and supplying mechanism of anti-cancer drugs and the management of new anti-cancer drugs.

关 键 词：医保谈判 抗肿瘤药物 用药金额 药物利用分析 合理用药 

分 类 号：R95[医药卫生—药学]